Condensed pyrimidine derivatives antitumor agents
    1.
    发明公开
    Condensed pyrimidine derivatives antitumor agents 失效
    Kondensierte Pyrimidinderivate als Antitumorverbindungen。

    公开(公告)号:EP0530579A1

    公开(公告)日:1993-03-10

    申请号:EP92114005.9

    申请日:1992-08-17

    申请人: Eisai Co., Ltd.

    CPC分类号: C07D487/04 C07D239/70

    摘要: A novel pyrimidine derivative having an excellent antitumor activity, which is represented by the following general formula (I) or a pharmacologically acceptable salt thereof:

       wherein R¹ represents a hydroxyl or amino group; R² represents a phenylene, pyridinediyl, thiendiyl, furandiyl or thiazoldiyl group, -CO₂R⁵ and -CO₂R⁶ may be the same or different from each other and each represents a carboxyl group or a carboxylic acid ester, the part 〉X-Y-Z- represents 〉N-CH₂-CH₂-, 〉N-CH=CH- or 〉CH-CH₂-CH₂-, A represents an oxygen atom, a group represented by the formula:

    (wherein R³ and R⁴ may be the same or different from each other and each represents a hydrogen or halogen atom or a hydrocarbon group which may be substituted, or alternatively R³ and R⁴ may be united to form an alkylidene group which may be substituted) or a group represented by the formula:

    (wherein R⁷⁰ represents a hydrogen atom or a hydrocarbon group), and n is an integer of 1 to 3, provided that the compound in which R¹ represents oxygen, and hydrogen is attached to nitrogen at 3-position is included in the above shown definition, a process for preparation the same, and an antitumor drug containing the same.

    摘要翻译: 一种具有优异抗肿瘤活性的新型嘧啶衍生物,其由下列通式(I)表示或其药理学上可接受的盐:其中R 1表示羟基或氨基; R 2表示亚苯基,吡啶二基,噻二烷基,呋喃基或噻二唑基,-CO 2 R 5和-CO 2 R 6可以相同或不同,各自表示羧基或羧酸酯, 部分&rdurule&XYZ-表示&rdurule&N-CH2-CH2-,&rdurule&N-CH = CH-或&rdurule&CH-CH2-CH2-,A表示氧原子,由下式表示的基团:其中R 3 >和R 4可以相同或不同,并且各自表示氢或卤素原子或可被取代的烃基,或者R 3和R 4可以一起形成亚烷基 可以被取代的基团)或由下式表示的基团:其中R 7表示氢原子或烃基,n表示1〜3的整数,条件是化合物 其中R 1表示氧,并且氢在3-位上与氮连接,包括在上述定义中,其制备方法和 抗肿瘤药含有相同的药物。